ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 749

$1.17M Total Retail Price of All Prescriptions

Rank: 20 out of 749

483 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 8,894 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 523 466 1 1
LOSARTAN POTASSIUM 478 429 2 9
FUROSEMIDE 387 360 3 2
LISINOPRIL 326 311 4 4
DIOVAN 266 248 5 14
SIMVASTATIN 263 241 6 5
OMEPRAZOLE 228 202 7 6
RENVELA 205 146 8 3
CARVEDILOL 204 183 9 11
CALCITRIOL 198 196 10 17
CLINISOL 191 191 11 39
ACTOS 163 156 12 70
HYDROCHLOROTHIAZIDE 159 148 13 27
CALCIUM ACETATE 156 127 14 16
TRAMADOL HCL 153 143 15 47
BENAZEPRIL HCL 142 127 16 23
PANTOPRAZOLE SODIUM 125 103 17 30
ATORVASTATIN CALCIUM 122 108 18 18
JANUVIA 121 119 19 33
CLONIDINE HCL 119 78 20 15
LANTUS 115 114 21 36
LEVOTHYROXINE SODIUM 107 101 22 13
SENSIPAR 100 53 23 8
FAMOTIDINE 99 88 24 35
ATENOLOL 97 87 25 20
MEGESTROL ACETATE 93 92 R 26 69
METOPROLOL TARTRATE 93 84 26 7
GABAPENTIN 93 80 26 25
RISPERIDONE 90 81 29 115
HYDROCODONE-ACETAMINOPHEN 90 59 S3 29 12
TRAVASOL 90 68 10 29 128
TAMSULOSIN HCL 89 81 32 29
CLOPIDOGREL 87 78 33 42
ALLOPURINOL 86 77 34 10
ALENDRONATE SODIUM 86 86 34 40
ENALAPRIL MALEATE 82 73 36 62
PROCRIT 81 70 37 66
DONEPEZIL HCL 77 77 38 55
PIOGLITAZONE HCL 68 61 R 39 185
METOCLOPRAMIDE HCL 65 39 40 74
COLCRYS 63 62 41 107
LACTULOSE 61 53 42 120
METOPROLOL SUCCINATE 60 59 43 26
WARFARIN SODIUM 58 57 44 31
NOVOLOG 56 56 45 139
PLAVIX 56 50 45 56
POTASSIUM CHLORIDE 54 52 47 37
GEMFIBROZIL 54 32 47 129
CRESTOR 54 47 47 43
TRIAMCINOLONE ACETONIDE 53 52 50 85
FLUDROCORTISONE ACETATE 51 50 51 208
ADVAIR DISKUS 51 50 51 89
ZOLPIDEM TARTRATE 50 49 53 24
PREDNISONE 50 44 53 28
PRAVASTATIN SODIUM 50 40 53 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.